Pertussis resurgence among vaccinated children in Khairpur, Sindh, Pakistan

Public Health

Volumn 126, Issue 6, 2012, Pages 518-522

  Mughal, A ^a   Kazi, Y F ^a   Bukhari, H A ^b   Ali, M ^b  

^a SHAH ABDUL LATIF UNIVERSITY   (Pakistan)

^b COMSATS Institute of Information Technology ^*  (Pakistan)

Author keywords

Bordetella pertussis; Children; Pertussis; Vaccination

Indexed keywords

AGAR; CHARCOAL; PERTUSSIS VACCINE;

BACTERIAL DISEASE; CHILD; ETIOLOGY; IMMUNIZATION; VACCINATION;

ANALYTIC METHOD; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BIOCHEMISTRY; BORDET GENGOU MEDIUM; BORDETELLA PERTUSSIS; CHILD; COUGH PLATE METHOD; COUGHING; CULTURE MEDIUM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PAKISTAN; PERTUSSIS; POLYMERASE CHAIN REACTION; RECURRENT DISEASE; SYMPTOM; VACCINATION;

ANTIGENS, BACTERIAL; BORDETELLA PERTUSSIS; CHILD; CHILD, PRESCHOOL; COUGH; DISEASE OUTBREAKS; FEMALE; HUMANS; INFANT; MALE; PAKISTAN; PERTUSSIS VACCINE; VACCINATION; WHOOPING COUGH;

PAKISTAN; SIND;

BORDETELLA PERTUSSIS;

EID: 84862202957     PISSN: 00333506     EISSN: 14765616     Source Type: Journal    
DOI: 10.1016/j.puhe.2012.02.001     Document Type: Article

References (30)

1. Cherry J.D., Heininger U. Pertussis and other Bordetella infections. Textbook of pediatric infectious diseases 2004, 1588-1608. The W. B Saunders Co, Philadelphia, Pa. 5th ed. R.D. Feigin, J.D. Cherry, G.J. Demmler, S. Kaplan (Eds.).
2. Cotter P.A., Miller J.F. Bordetella. Principles of bacterial pathogenesis 2001, 619-674. Academic Press Ltd, London, United Kingdom. E.A. Groisman (Ed.).
3. Crowcroft N.S., Pebody R.G. Recent developments in Pertussis. Lancet 2006, 367:1926-1936.
4. Cherry J.D., Mattoo S. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005, 326-382.
5. Cassiday P., Sanden G., Heuvelman K., Mooi F.R., Bisgard K.M., Popovic T. Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States 1935-1999. J Infect Dis 2000, 182:1402-1408.
6. de Melker H.E., Schellekens J.F., Neppelenbroek S.E., Mooi F.R., Rumke H.C., Conyn-van Spaendonck M.A. Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data. Emerg Infect Dis 2000, 6:348-357.
7. Mooi F.R., Van Loo I.H., King A.J. Adaptation of Bordetella Pertussis to vaccination: a cause for its reemergence?. Emerg Infect Dis 2001, 7:526-528.
8. Guris D., Strebel P.M., Bardenheier B., Brennan M., Tachdjian R., Finch E., et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis 1999, 28:1230-1237.
9. Gzyl A., Augustynowicz E., Rabczenko D., Gniadek G., Slusarczyk J. Pertussis in Poland. Int J Epidemiol 2004, 33:358-365.
10. Poynten M., McIntyre P.B., Mooi F.R., Heuvelman J.K., Gilbert G.L. Temporal trends in circulating Bordetella Pertussis strains in Australia. Epidemiol Infect 2004, 132:185-193.
11. Tanaka M., Vitek C.R., Pascual F.B., Bisgard K.M., Tate J.E., Murphy T.V. Trends in pertussis among infants in the United States, 1980-1999. JAMA 2003, 290:2968-2975.
12. Weber C., Boursaux-Eude C., Coralie G., Caro V., Guiso N. Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years. J Clin Microbiol 2001, 39:4396-4403.
13. Elomaa A., Advani A., Donnelly D., Antila M., Mertsola J., Hallander H., et al. Strain Variation among Bordetella Pertussis Isolates in Finland, where the whole-cell pertussis vaccine has been used for 50 years. J Clin Microbiol 2005, 3681-3687.
14. King A., van Gorkom T., Pennings J.L., van der Heide Han G.J., He Qiushui, Diavatopoulos D., et al. Comparative genomic profiling of Dutch clinical Bordetella pertussis isolates using DNA microarrays: identification of genes absent from epidemic strains. BMC Genet 2008, 9:311. 10.1186/1471-2164-9-311.
15. McPheat W.L., McNally T. Phase I and phase IV strains of Bordetella pertussis carry a repeated DNA sequence not found in other Bordetella species. FEMS Microbiol Lett 1987, 41:357-360.
16. McPheat W.L., McNally T. Isolation of a repeated DNA sequence from Bordetella pertussis. J Gen Microbiol 1987, 133:323-330.
17. Reischl U., Lehn N., Sanden G.N., Loeffelholz M.J. Real-time PCR assay targeting IS481 of Bordetella pertussis and molecular basis for detecting Bordetella holmesii. J Clin Microbiol 2001, 39:1963-1966.
18. van der Zee A., Agterberg C., Peeters M., Schellekens J., Mooi F.R. Polymerase chain reaction assay for pertussis: simultaneous detection and discrimination of Bordetella pertussis and Bordetella parapertussis. J Clin Microbiol 1993, 31:2134-2140.
19. World Health Organization Pertussis surveillance 2005, Department of Vaccines and Biologicals, Geneva, Switzerland. http://www.who.int/vaccines-documents/DocsPDF01/www.605.pdf.
20. Pearl K., Eldering G. Cough plate examination for B. pertussis. Am J Publ Health 1934, 24(4):309-318.
21. Hai-Rong, Jiang N. Extremely rapid extraction of DNA from bacteria and yeasts. Biotechnol Lett 2006, 28:55-59. @ Springer.
22. Karen B.R., Gary N.S. Prevalence and sequence variants of IS481 in Bordetella bronchiseptica: implications for IS481-based detection of Bordetella pertussis. J Clin Microbiol 2006, 44:4577-4583.
23. Templeton K.E., Scheltinga S.A., van der Zee A., Bram M., Diederen W., Kruissen A.M., et al. Evaluation of real-time PCR for detection of and discrimination between B. pertussis, B. parapertussis and B. holmesii for clinical diagnosis. J Clin Microbiol 2003, 41(09):4121-4126.
24. Linnemann C.C., Bass J.W. Bordetella infection. Diagnostic procedures for bacterial, mycotic and parasitic infection 1991, American Public Health Association Inc., Washington D.C. 6th ed. A. Balows, W.J. Hausler (Eds.).
25. Jenkinson D. Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study. Br Med J 1988, 296:612-614.
26. Edwards K.M., Karzon D.T. Pertussis vaccines. Ped Clin North Am 1990, 37:549-566.
27. Diavatopoulos D.A., Cummings C.A., Schouls L.M., Brinig M.M., Relman D.A., Mooi F.R. Bordetella pertussis, the causative agent of whooping cough, evolved from a distinct, human-associated lineage of B. bronchiseptica. PLoS Pathog 2005, 1:e45.
28. E! Science News Pakistan Introduces vaccine to prevent top child killer November 1, 2008-in Health & Medicine, . http://www.sciencedaily.com/releases/2008/11/081101083930.htm.
29. Ali M.A., Bukari H. Adult and adolescent pertussis should not be underestimated. Pak J Med Sci 2010, 26(1):44-45.
30. Emmanual G., Begue P., Anjak I., Betsou F., Guiso N. Comparison of polymerase chain reaction, culture, and western immunoblot serology for diagnosis of Bordetella pertussis infection. J Clin Microbiol 1993, 2745-2750.